Clinical trials - Press Releases

Date	Title	Company
09-Sep-2021	Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies	Repligen and Navigo GmbH
09-Sep-2021	Sanofi provides update on Phase 3 study evaluating rilzabrutinib for the treatment of pemphigus	Sanofi
09-Sep-2021	Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza	Novavax
09-Sep-2021	Automated recruitment platform accelerates patients into clinical studies significantly faster than traditional manual methods	uMed
08-Sep-2021	OXURION to Present Clinical and Pre-Clinical Data at Upcoming EURETINA 2021 Virtual Congress	OXURION
08-Sep-2021	ISA Pharmaceuticals Commences Patient Treatment in Third Phase 2 Clinical Trial with the Combination of ISA101b and Libtayo® (cemiplimab)	ISA Pharmaceuticals
07-Sep-2021	Medrio, Inc. and PHASTAR Unite to Offer Data Visualization for Clinical Trials	PHASTAR
07-Sep-2021	Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain	Cryoviva Singapore
06-Sep-2021	Newron Initiates First Potentially Pivotal Study with Evenamide in Patients with Schizophrenia	Newron
06-Sep-2021	Evotec partner Bayer: Phase IIb trial shows eliapixant significantly decreases cough frequency in patients with refractory chronic cough	Evotec
31-Aug-2021	CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services	CellCarta
31-Aug-2021	Kinnov-Therapeutics completes recruitment of KT-110 Phase 2 clinical trial in alcohol dependence disorders	Kinnov-Therapeutics
31-Aug-2021	New Data Demonstrate the Benefits of Early Use of UPTRAVI® (selexipag) in Delaying Disease Progression in a Broad Population of Patients with Pulmonary Arterial Hypertension (PAH)	Janssen Pharmaceutical Companies of Johnson & Johnson
31-Aug-2021	uniQure Announces Completion of Additional Patient Procedures Following Positive Recommendation from Data Safety Monitoring Board in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease	uniQure N.V.
31-Aug-2021	Dupixent® (dupilumab) pivotal trial meets all primary and secondary endpoints becoming first biologic medicine to significantly reduce signs and symptoms of moderate-to-severe atopic dermatitis in children as young as 6 months	Sanofi
31-Aug-2021	Landmark clinical trial demonstrates empagliflozin (Jardiance®) is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction (HFpEF)	Boehringer Ingelheim
27-Aug-2021	Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer.	Clinerion Ltd.
26-Aug-2021	Innovative ICR-discovered drug to enter first clinical trial, targeting HSF1 pathway	The Institute of Cancer Research, London
26-Aug-2021	Novavax to Participate in OCTAVE-DUO Study to Evaluate Third Dose of Vaccine in Participants with Impaired Immune Systems	Novavax
26-Aug-2021	HUTCHMED Initiates a Phase Ib/II Trial of Fruquintinib in Combination with Tislelizumab in Advanced Triple Negative Breast Cancer or Advanced Endometrial Cancer	HUTCHMED